Another CI product that has proven valuable in the academic as well as the commercial sectors is Clavariate Integrity. The daily-updated content stands at 457,000 compounds with documented biological activity and 297,000 patent family records. This has useful orthogonality to SF in the domains of commercial pipeline collations (but as for CiteLine also ADEV pipelines are not explicitly covered) target identification, mmoa and clinical data linked to associated diseases and therapies. The latter is particularly difficult to get cleanly from public sources (n.b. while the NLM ClinicalTrials.gov now indexes 307,479 research studies from 210 countries it does not substitute for a well-curated CI database). As an example of the importance of accessing Integrity (or any commercial offering with similar coverage) it is used to screen projects and targets being proposed for SciLifeLab DDD. It turns out that some of these proposals have been stopped because the teams were unaware of the extent of competitive impingement for their target and indication that was revealed by the Integrity queries (Per Arvidsson, personal communication).